EVOK - Evoke Pharma Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript
Evoke Pharma, Inc. EVOK Q1 2022 Earnings Conference Call May 10, 2022, 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Quesenberry – Chief Commercial Officer, EVERSANA Matthew D'Onofrio – Chief Business Officer Daniel Kontoh-Boateng – Investor Relations Conference Call Participants Yale Jen – Laidlaw and Company Mitchell Kapoor – H.C. Wainwright & Co., LLC Presentation Operator Please stand by. Your program is about to begin. [Operator Instructions] Good afternoon and welcome to the Evoke Pharma First Quarter 2022 Earnings Conference Call. Currently all callers have been placed in listen-only mode and following management's prepared remarks, the call will be open up for questions. [Operator Instructions] Please be advised that today's call is being recorded. I would like to turn the call over to Daniel Kontoh-Boateng. Thank you. You may begin. Daniel Kontoh-Boateng Good afternoon and thank you for participating in Evoke Pharma's conference call today. With
For further details see:
Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript